Share Name Share Symbol Market Type Share ISIN Share Description
Nmc Health Plc LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -65.00 -2.5% 2,530.00 527,004 16:35:04
Bid Price Offer Price High Price Low Price Open Price
2,533.00 2,537.00 2,606.00 2,512.00 2,567.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2,057.25 256.85 119.60 21.2 5,280
Last Trade Time Trade Type Trade Size Trade Price Currency
17:44:07 O 1 2,556.00 GBX

Nmc Health (NMC) Latest News (1)

More Nmc Health News
Nmc Health Takeover Rumours

Nmc Health (NMC) Discussions and Chat

Nmc Health Forums and Chat

Date Time Title Posts
07/12/201900:35NMC Health1,605
26/4/201916:25One of the best stocks-
03/9/201219:50North Midland Construction - strong buy trading on a p/e of 4x for this year2

Add a New Thread

Nmc Health (NMC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Nmc Health trades in real-time

Nmc Health (NMC) Top Chat Posts

Nmc Health Daily Update: Nmc Health Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker NMC. The last closing price for Nmc Health was 2,595p.
Nmc Health Plc has a 4 week average price of 2,218p and a 12 week average price of 2,149p.
The 1 year high share price is 3,256p while the 1 year low share price is currently 1,773.50p.
There are currently 208,714,264 shares in issue and the average daily traded volume is 970,122 shares. The market capitalisation of Nmc Health Plc is £5,280,470,879.20.
aquaesulis01: I'll stick my head above the parapet and say that I appreciate research based comments from both bull and bear contributors as it helps to provide a balanced view of both the short and mid/long term company prospects and market sentiment. Yertiz has a short term view that is pessimistic based on trend whilst rabbitfoot has countered with a candlestick pattern view based on a golden cross. At the end of the day it is news that will shift this substantially in one direction or another and on previous history an RNS normally has a positive effect on the share price because NMC have a good story to tell. My previous reference to the value of the health data held by NMC which has not been factored into the target share price by any of the analysts is valid, The CEO CMD presentation slide pack at slide 53 shows the basis for the $51 Billion unrealised benefit attributed to data hTTps://
yertiz: Good points well made, steeplejack. No one can forecast share price movement with any accuracy on an hour by hour, day by day basis, but they can see how trends are set, how companies are positioned and what influences decisions made by hedge funds, shorters and the like have on the company's fortunes over a period of time. This particular time for NMC has seen an influx of ramping posts on ADVFN (mostly by non-entities or Bots) trying to influence private investors to buy when most of the markers and signs are to sell. I question that motive and would dearly like to know who is/are actually behind some of those meaningless and posturing posts. The hint of a bad report from one shorting company sent NMC spiralling downwards, though the rumours appear unfounded, but there's no smoke without fire, and that is what is currently holding NMC back. No news is good news, but any vestige of weakness in a seemingly 'good' report tears the co to shreds. I would also like to know how much influence these rampers (bot drivers) believe they have on a BB on ADVFN, to my mind extremely little judging by the number of posters on NMC. I dislike ramping, I abhor shorting but they are all part of investment life and anyone basing their research and investment choice on a BB deserves exactly what they get. Take everything with a large pinch of salt. GLA, but as of this morning, I'm out of NMC completely until sub £20 is reached.
steeplejack: Yes AQR are looking to slide out the back door.I can’t see that they’re banking a profit on these most recent trades. Analysts at Berenberg raised their target price on healthcare provider NMC Health from £36 to £40 on Wednesday (18 Sept)stating that its bear case was "going into hibernation" following the group's recent first-half results. Berenberg said NMC's interim results brought with them an inflexion point for the group's shares and argued that persistently strong fundamental trends had now come back into market focus, striking a positive chord with investors, while further diminishing the bear case. Strong fundamentals across the board were further supported by NMC announcing an opportunistic share buyback programme of up to $200m, which was intended to capitalise on what Berenberg, and the company, viewed as "a materially undervalued share price". "We increase our price target to £40.00 (from £36.00 previously), reflecting higher revenue expectations, improved cash dynamics and better visibility on the fundamental drivers," said the German bank. Berenberg also expects to see NMC's "impressive" momentum in organic growth for underlying earnings and revenues continue, pointing out that there was "little reason" why it should not sustain this performance in the "years to come". The analysts felt the company was about to enter "a new phase", shifting away from large-scale mergers and acquisition in order to focus on integrating its acquired businesses and maturing operational beds, which they expect to drive margin expansion and support further double-digit top-line growth. "We believe this shift in focus will continue to be appreciated by the market, lowering the risk profile of the business, allowing for improved cash dynamics and enabling the underlying business to accelerate on the back of previous CAPEX investments," said Berenberg. Feedback
mohdusman44: The functions that I would like see a great improvement within NMC is its PR and IR team. Both these departments seems not upto the mark during the share price fall. Nmc could have handled and arrested the share price fall aided by shorts and post the Muddywater episode in a much better and effective manner preventing the share price from nosediving. Investors were clueless and in a panic mode. A proper communique on a timely manner plus a good PR would have avoided this situation wherein investors ended burning their fingers.
mohdusman44: @Alexak1, keeping a close watch at what price the company will be doing the buy backs. Looks like this time, NMC share price will beat TP recommended by the Analysts. As NMC's CEO rightly commented in its HY results announcement, there is big disconnect between fundamentals and valuation which is bound to get corrected soon. The stock should be somewhere around gbp 2500, by the time the management is done with its road shows covering multi-continents.
aquaesulis01: KNOW YOUR OPPONENTS AQR who have led the short attack have done so on the basis of a report from "The Analyst" based on a forecast of slowing growth and rising debt; their shorting target appears to be 16.60 hTTps:// This report is at odds with the Mar 19 Full Year RNS which stated that "management remains confident with near to medium term outlook, as reflected by the guidance of continued strong growth provided for 2019 (+22-24% YoY revenue growth and +18-20% YoY EBITDA growth)". On the debt front, at 2018 year-end net debt-to-EBITDA stood at 3.1x (2017: 2.9x). The outlook for net debt in the Full Year RNS was for Year-end net-debt to EBITDA to further reduce to 2.2-2.4x. Since the EOY RNS, the closing of KSA Joint Venture transaction and 2019 earnings guidance update end of May upgraded the EBITDA guidance:to USD 575-585m (previous guidance: USD 566-576m). We have subsequently been informed on the 8th August by RNS that NMC notes the recent share price weakness and confirms that it expects to report that, after a good performance in the first half of 2019, trading in the business remains in line with management expectations on all key metrics including revenue, EBITDA, net income, leverage, cash flow conversion and working capital. Full year guidance remains as previously stated. This resulted in Barclays lifting its price target to 4,275p from 4,100p on Friday 9th August, saying first-half results later in the month should be a positive catalyst, particularly after recent share price weakness. Add in the confidence shown by the CEO purchase of shares just before the close period and I personally would rather be long than short on this share at the current share price with just 3 trading days left to the Half Year results but DYOR
nsee700: lets say this price is being dictated by a SWF like ADIA or SIA then it should still be bought to the regulators attention for manipulation! Agreed some of the slip in share price has to do with market sentiment such as trade wars with US and China, Germany, US, UK slipping into the negative for the first time, general slowdown in the Middle East and the knock on effect of that on NMC share price. It still does not explain the drop to 4,000 to 1,800 in a matter of less than a year
alexka1: Here is the CITI note published 2 days ago... as i said over 20% if short - this is the time to buy, its so crowded as a trade on no news. just ppl getting on a trade without reasons following the few big HFs and recent price slumps. NMC Health (NMC.L) Alert: Stock down >10% on no news, our thoughts... The NMC share price is 10-15% lower in afternoon trading, and we see no company-specific or industry news flow. We struggle to explain the move based on fundamentals but offer thoughts on what might be driving the shares weaker, however unjustified we think the move is: – Yesterday, NMC’s shares fell ~7% on no news flow as well: We believe that some investors might have drawn negative conclusions regarding NMC from a tweet by Muddy Waters Research about a new publication released on 7 August. The stock in this publication turned out to be Burford Capital Ltd (BURF.L, not rated), which today is trading ~50% lower. The knock-on effects of this severe move for Burford could be impacting NMC’s share price (on risk aversion). – The influence of the shorts could be accentuating these moves: >20% of NMC’s float is shorted currently, and a large portion of the short positions are at momentum funds, which could be compounding the price action. With Monday’s positive development of the partial removal of pledged stock by insiders, some active shorts may see time as running out for the forced selling to be triggered related to pledged stock (see NMC Health - Partial pledge removal). Total removal of the pledge would dent the bear case, in our view. Active shorts might be opportunistically aggressive in their selling now. – Lack of buyers to step in is concerning, to us: We are surprised that NMC bulls didn’t see good enough value or have high enough conviction in the stock to apprehend a slide of this quantum. – We like the fundamental story and continue to rate NMC a Buy: Modest EPS cut, big TP cut to reflect new reality. Retain Buy. Citi Research Equities Health Care Facilities CEEMEA │ United Arab Emirates
alexka1: News NMC Health Confirms "Good" Interim Performance Amid Share Price Fall (Alliance News) - Private healthcare operator NMC Health PLC confirmed Thursday the first half of ... Alliance News8 August, 2019 | 12:23PMEmail Form (Alliance News) - Private healthcare operator NMC Health PLC confirmed Thursday the first half of 2019 had delivered a "good" performance with trading in line with expectations. The Gulf-focused firm made the announcement after noting recent "share price weakness" since the start of August. Shares in NMC were 5.5% higher at 2,109.00 pence in London on Thursday, however shares have still shed 15% since the start of August. NMC emphasised performance over the six months ended June was "good" and that trading "remains in line with management expectations" on all key metrics including revenue, earnings before interest, taxes, depreciation & amortisation and leverage. Full year guidance also remains as previously stated.
smartinvest1: Nmc share price should go up as VIX is going up.
Nmc Health share price data is direct from the London Stock Exchange
Your Recent History
Nmc Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191208 10:44:50